Can a TB fact sheet be electronically signed?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided you document signer intent, consent to electronic records, attribution, and retain a reproducible record.

Do I need patient consent before e‑transmitting results?

Use HIPAA‑compliant channels and obtain patient consent when required for disclosures beyond treatment, payment, or public health reporting. HIPAA rules and local public health laws determine permitted uses.

Is notarization required for TB fact sheets?

Not typically. Notarization is uncommon for clinical screening forms unless an employer or specific state rule requires it; check state notary or employer policy before adding notarization.

How long must I keep TB screening records?

Follow HIPAA minimums (6 years from creation or last effective date, 45 CFR §164.530(j)) and any state law that may require longer retention for medical or occupational records.

What happens if a form is incomplete?

Incomplete forms can delay care, impede public health investigations, and create legal risk. Implement required fields and QA checks to reduce omissions.

Can vendor platforms store PHI for TB forms?

Yes if the vendor will execute a Business Associate Agreement (BAA) and demonstrates HIPAA controls: encryption, audit logs, access controls, and incident response procedures.

Electronic Signature
Templates
Healthcare
Healthcare TB Fact Sheet

Healthcare TB Fact Sheet

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE TB FACT SHEET

Facility Name:

Patient Information

Patient Full Name

Date of Birth: Gender:

Address

Phone: Emergency Contact:

Insurance Information (if applicable)

Insurance Provider

Policy Number: Group Number:

Subscriber Name

Medical History

Current Medications Allergies Prior Surgeries / Chronic Conditions

TB History and Risk Assessment

Have you ever had tuberculosis (TB) or been treated for TB? Yes No

If yes, describe prior diagnosis/treatment

Have you received BCG vaccine? Yes No If yes, approximate year:

Recent known exposure to a person with active TB? Yes No If yes, date of exposure:

Risk Factors (check all that apply)

HIV infection Immunosuppression (steroids, chemotherapy) Diabetes Homelessness or recent incarceration

Symptoms

Do you currently have any of the following symptoms? Check all that apply.

Cough lasting more than 2–3 weeks Fever or night sweats Unintended weight loss Persistent fatigue

Testing Information

TB Skin Test (Mantoux) Date: Administered by:

Induration (mm): Interpretation: Positive Negative

IGRA (Blood Test) Date: Result:

Chest X-ray (if performed) - Date and Findings

Treatment and Risks

If latent TB infection or active TB disease is diagnosed, treatment is recommended to reduce the risk of progression and to limit transmission. Recommended medications vary by diagnosis and patient factors; common regimens may include isoniazid, rifampin, rifapentine, or combination therapy.

Potential adverse effects of TB medications may include hepatotoxicity (liver injury), gastrointestinal symptoms, allergic reactions, and interactions with other medications. Patients will be monitored with clinical assessment and laboratory testing as indicated.

If treatment is recommended, summary provided to patient

Confidentiality, Reporting, and Patient Rights

Information about suspected or confirmed active TB disease is reportable to public health authorities as required by law. Such reporting is necessary for public health follow-up, contact investigation, and to ensure appropriate treatment and prevention. Information disclosed for reporting is limited to case-identifying data and clinical information necessary for public health purposes.

You have the right to refuse TB testing and the right to withdraw consent for testing or treatment at any time. Refusal of testing or treatment may affect eligibility for certain services, employment, or communal living placements where screening is required. Declining testing may also limit the ability of clinicians to determine appropriate care.

Authorization Expiration Date (if applicable)

Acknowledgment and Consent

I acknowledge that I have received and read this TB Fact Sheet, including information on transmission, testing, treatment options, potential risks, and reporting obligations. I have had the opportunity to ask questions and my questions have been answered to my satisfaction.

I have received and understand the information in this TB Fact Sheet.

Consent for testing (select one): I consent to TB testing (skin test and/or blood test as clinically indicated). I decline TB testing at this time.

If declining testing, reason (optional)

Authorization to disclose necessary medical information to public health authorities for case reporting and contact investigation: I authorize disclosure as required by law.

Patient Name:

Signature:

Date:

If signed by guardian or representative, print name and relationship:

Representative Signature (if applicable):

What the Healthcare TB Fact Sheet Is and When It’s Used

The Healthcare TB Fact Sheet is a standardized document used by healthcare providers, public health programs, and occupational health services to record tuberculosis screening results, risk assessment, test dates, and provider recommendations. It typically documents Mantoux (TST) or IGRA test results, chest x‑ray findings when applicable, treatment status, and follow‑up instructions. The form supports clinical decision making, workplace clearance, and reportable‑disease tracking where state law requires notification of active tuberculosis cases or exposures.

Why a Clear TB Fact Sheet Matters

A concise TB fact sheet ensures consistent patient records, supports timely public health reporting, and documents clinical decisions and follow‑up. Accurate forms reduce administrative friction, help meet regulatory retention standards, and protect patient and workplace safety.

Who Prepares and Reviews This Form

Recipients often include the patient, employer health services, and local health departments when state reporting rules apply.

Occupational health teams that clear employees for work following exposure or screening
Primary care or public health clinics documenting patient TB test results and recommendations
Hospital infection control units tracking exposures, follow‑up, and reportable cases

Essential Sections to Include on a Professional TB Fact Sheet

A complete TB fact sheet organizes identification, test results, clinical interpretation, treatment or referral recommendations, reporting actions, and signatures. Consistent structure improves clarity for care teams and public health authorities.

Patient Identification

Full legal name, date of birth, medical record or employee ID, and contact information for reliable matching with public health records.

Screening Details

Type of test (TST or IGRA), administration and reading dates, lot numbers if available, and measured induration in millimeters for TST.

Clinical Findings

Result interpretation (positive/negative/indeterminate), chest x‑ray date and summary when indicated, and any symptoms consistent with active TB.

Treatment / Follow‑up

Start and planned completion dates for latent TB infection therapy or referral to TB clinic for active disease; document next evaluation date.

Reporting / Notifications

State or local health department reporting status, date reported, and name of the person who submitted the report when required by jurisdictional rules.

Provider Signature

Printed name, professional title, electronic or handwritten signature, and date to authenticate the record and support legal admissibility.

Stepwise Process to Complete and File the TB Fact Sheet

Follow these standard steps to capture the clinical and administrative elements accurately.

01

Gather ID: Confirm full legal name and DOB before testing.
02

Perform Screening: Administer TST or collect IGRA specimen per clinical protocol.
03

Record Results: Enter induration, lab result, or x‑ray findings immediately.
04

Sign and Route: Authenticate the form and route to employer or public health if required.

How Electronic Completion and Routing Typically Work

Digital workflows reduce delays between testing, documentation, and necessary reporting while preserving an audit trail.

Upload: Scan or open the TB fact sheet template in the e‑forms system.
Populate Fields: Complete patient and test fields using validated formats.
Authenticate: Signer confirms identity via email, SMS, or stronger methods.
Route: Send copies to patient, employer, and health department where required.

Typical Digital Workflow Settings for TB Fact Sheet Processing

Configure the form and routing settings to match your clinical and reporting needs before deployment.

Field	Configuration
Required Fields	Full name \| DOB \| Test type \| Result
Authentication	Email verification \| SMS code optional
Routing	Send to patient \| Employer HR \| Local health dept
Audit Options	Capture IP, timestamp, and signer role

Technical Considerations for Digital Completion and Submission

Choose a platform that supports HIPAA (BAA), encryption in transit and at rest, and integration with your records systems to minimize manual handling.

Formats: PDF, DOCX supported
Integrations: EHR and cloud storage
Authentication: Email, SMS, or stronger

Timing and Reporting Expectations

Timelines for reporting and follow‑up vary by jurisdiction and case status; understand local public health rules to meet deadlines.

Immediate Reporting:

Some states require immediate notification for suspected active TB cases.

Routine Notification:

Latent TB infection notifications typically follow clinic reporting schedules.

Employer Clearance:

Workplace clearance often requires documentation within days of testing.

Follow‑up Appointments:

Schedule treatment evaluations per clinical protocol (timing varies).

Record Updates:

Amend records promptly when new test results are received.

Common Preparation Errors to Avoid

Leaving out unique identifiers (MRN or DOB) delays matching with lab and public health records and may require re‑contacting the patient.
Recording 'positive' without documenting measurement or test type prevents appropriate clinical interpretation and proper public health classification.
Using inconsistent date formats or shorthand can cause misinterpretation; use MM/DD/YYYY consistently across the form.
Failing to record who reported to public health or when creates gaps in the chain of custody and complicates outbreak investigation.

Risks and Consequences of Incomplete or Misfiled Forms

HIPAA Violation: Civil fines possible

Public Health Delay: Case tracking impeded

Workplace Exposure: Increased transmission risk

Legal Liability: Potential employer disputes

Data Integrity: Audit trail gaps

Reputational Harm: Loss of trust

Security and Compliance Checklist

Encryption: AES‑256 at rest

Transport: TLS 1.2/1.3 in transit

HIPAA: BAA required

Audit Trail: IP and timestamp capture

Access Controls: Role‑based permissions

Standards: SOC 2 / ISO 27001 available

How the TB Fact Sheet Differs from Related Forms

Contrast common adjacent documents so users know when to use a TB fact sheet versus other health or workplace clearance forms.

Document Type	Purpose	Typical Use
TB Fact Sheet	screening record	clinical and public health reporting
General Health Clearance	fit for duty	broader occupational criteria
Vaccination Record	immunization status	vaccine documentation only
Infectious Disease Report	public health alert	formal report to health dept

Representative eSignature Pricing and Capability Comparison

Compare common vendor starting prices and key capabilities relevant to healthcare forms; signNow is listed first for direct comparison.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card required	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes (BAA)	Yes (BAA)	Yes (BAA)	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions About the Healthcare TB Fact Sheet

Answers to common operational and legal questions when creating, signing, and retaining TB screening records.

Need help? Contact support

Can a TB fact sheet be electronically signed?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided you document signer intent, consent to electronic records, attribution, and retain a reproducible record.
Do I need patient consent before e‑transmitting results?
Use HIPAA‑compliant channels and obtain patient consent when required for disclosures beyond treatment, payment, or public health reporting. HIPAA rules and local public health laws determine permitted uses.
Is notarization required for TB fact sheets?
Not typically. Notarization is uncommon for clinical screening forms unless an employer or specific state rule requires it; check state notary or employer policy before adding notarization.
How long must I keep TB screening records?
Follow HIPAA minimums (6 years from creation or last effective date, 45 CFR §164.530(j)) and any state law that may require longer retention for medical or occupational records.
What happens if a form is incomplete?
Incomplete forms can delay care, impede public health investigations, and create legal risk. Implement required fields and QA checks to reduce omissions.
Can vendor platforms store PHI for TB forms?
Yes if the vendor will execute a Business Associate Agreement (BAA) and demonstrates HIPAA controls: encryption, audit logs, access controls, and incident response procedures.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now